This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
fin-tech: Archive
Intuit vs. BILL Holdings: Which Fintech Stock is the Better Buy?
by Rohit Vasant Fatarpekar
INTU and BILL both posted strong Q2 fiscal 2026 growth, but their AI, payments, and SMB platform strategies shape which fintech stands out.
INTUPositive Net Change BILLPositive Net Change
fin-tech
SOFI Technologies to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
SOFI heads into Q1 earnings with strong growth forecasts and a solid surprise history, but a negative ESP clouds expectations for another beat.
VRSKPositive Net Change COHRNegative Net Change SOFINegative Net Change
earnings fin-tech finance
SoFi Technologies Stock Before Q1 Earnings: To Buy or Not to Buy?
by Shuvra Shankar Dey
SOFI heads into Q1 earnings with strong growth forecasts but a weak earnings ESP and rich valuation, leaving investors weighing upside potential against risk.
PYPLNegative Net Change SOFINegative Net Change XYZNegative Net Change
earnings-preview fin-tech finance
DAVE vs. NU: Which Fintech Stock Is the Better Buy Now?
by Arghyadeep Bose
Nu Holdings and Dave race to win fintech's underbanked market, but diverging growth, AI strategies and scale could shape which stock stands out now.
NUNegative Net Change DAVENegative Net Change
artificial-intelligence business-services fin-tech
JPM Off to a Solid 2026 Start: Should Investors Buy the Stock?
by Swayta Shah
JPMorgan's Q1 earnings beat expectations on record Markets and stronger IB, but a lower NII outlook, rising costs and valuation argue patience. Is it a buy?
BACPositive Net Change JPMNegative Net Change CNegative Net Change
banking earnings-estimates-revisions fin-tech finance
Bitcoin Surges Toward $80K in April: Should Investors Buy Crypto Now?
by Urmimala Biswas
Bitcoin nears $80K as easing tensions and soft inflation fuel short squeeze, but fading momentum, tight liquidity and Fed uncertainty temper outlook.
ETHPositive Net Change BTCNegative Net Change BTCNegative Net Change XRPNegative Net Change
bitcoin blockchain cryptocurrency fin-tech finance
PYPL Shares Slide 31.4% in 6 Months: Should You Buy the Dip or Sell?
by Rohit Vasant Fatarpekar
PayPal stock is down 31.4% in six months, but AI commerce, Venmo expansion and global PYUSD rollout could shape its next recovery phase.
MAPositive Net Change VNegative Net Change PYPLNegative Net Change
fin-tech reit
American Express vs. Affirm: Which Payments Stock Has More Upside?
by Rajshree Sipani
AFRM's surging BNPL growth and higher upside potential set it apart from AXP, despite AXP's stable spending trends and premium model strength.
AXPNegative Net Change AFRMNegative Net Change
artificial-intelligence computers cybersecurity e-commerce entertainment fin-tech finance internet luxury payments retail saas software
Monarch Casino (MCRI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MCRIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Broadcom Inc. (AVGO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AVGONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines